Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1High-Dose Dexamethasone Combined with Orelabrutinib
(D12160)		2件: Dexamethasone,
Orelabrutinib		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib (D12160) 💬 		2件: BTK,
NR3C1 💬 		8件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
2Orelabrutinib
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬5件: 13, 49, 53, 61, 63 💬
3Orelabrutinib (High Dose)
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
4Orelabrutinib (Low Dose)
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
5Orelabrutinib( higher dose)
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
6Orelabrutinib( lower dose)
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
7Orelabrutinib-100
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬
8Orelabrutinib-150
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬
9Orelabrutinib-50
(D12160)		1件: Orelabrutinib1件: Orelabrutinib (D12160) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬